clinical trial · NCT00092573
Study of Ezetimibe and Fenofibrate in Patients With Mixed Hyperlipidemia (0653-036)(COMPLETED)
Organon and Co·phase3·completed·n = 576
HypercholesterolemiaHypertriglyceridemiaMK0653, ezetimibeComparator: fenofibrate monotherapy
brief summary
The purpose of this study is to assess the cholesterol lowering safety and effectiveness of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).
started
Apr 1, 2003
primary completion
Nov 1, 2004
completion
Nov 1, 2004
last updated
Aug 15, 2024
detailed description
The duration of treatment is 48 weeks.
official title
Evaluation of the Efficacy and Safety of Fenofibrate and Ezetimibe Coadministration in Patients With Mixed Hyperlipidemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol